Replies to post #6867 on Value Microcaps Zip Code Changers

[bbotcs]

stock_peeker: ARNA/VVUS/OREX

Nice piece. "It is possible the FDA may only want to approve the best weight loss drug under review, which some would argue is Qnexa."

That is why I have put my money on VVUS, though had I listened to umiak earlier this year about ARNA, I would have tripled my money.

Vivus has an ED drug and is working on QNEXA for type II diabetes. If QNEXA is not approved, the stock will drop like a rock, but the company will survive.

I'm interested in seeing how the FDA's decision this week affects VVUS. If the ARNA decision is delayed, I think that might be very positive for Vivus because there is a mentality out there that this is a race to see who gets the first obesity drug in decades to market first.

If Arena's drug is denied approval, I think VVUS will sell off a little.

This is going to be very exciting this week. If ARNA's drug is approved and the stock pops to $20 (very unlikely, imo), I'll kick myself in the behind. We'll see.